CommercialCoverageMedium impact
Policy Criteria Change
Arkansas Blue Cross Blue Shield·AR · ENT (Ear, Nose & Throat), Sleep Medicine, Pulmonology·Medical Policy
Effective date
May 15, 2026
We identified it
Jun 19, 2026
Summary
Arkansas Blue Cross updated coverage criteria for hypoglossal nerve stimulation (Inspire device) for sleep apnea treatment, expanding coverage to include adolescents/young adults with Down syndrome (ages 10-18) in addition to adults, while excluding coverage for other FDA-approved devices like Genio.
Action Required
Before May 15, 2026: Billing team must update prior authorization requirements for hypoglossal nerve stimulation procedures to include new criteria for adolescent Down syndrome patients (ages 10-18) and ensure only Inspire device procedures are submitted for Arkansas Blue Cross members. Verify patient eligibility meets updated AHI, BMI, and CPAP failure criteria. Claims for non-Inspire devices (including Genio) will be denied.